118 related articles for article (PubMed ID: 3032804)
1. The development of a new agent for the treatment of inflammatory/allergic conditions.
Cairns H; Orr TS
Int Arch Allergy Appl Immunol; 1987; 82(3-4):513-7. PubMed ID: 3032804
[TBL] [Abstract][Full Text] [Related]
2. Airway constriction by isocapnic hyperventilation of cold, dry air: comparison of magnitude and duration of protection by nedocromil sodium and sodium cromoglycate.
Juniper EF; Kline PA; Morris MM; Hargreave FE
Clin Allergy; 1987 Nov; 17(6):523-8. PubMed ID: 2830047
[TBL] [Abstract][Full Text] [Related]
3. The effect of nedocromil sodium and sodium cromoglycate on antigen-induced bronchoconstriction in the Ascaris-sensitive monkey.
Eady RP; Greenwood B; Jackson DM; Orr TS; Wells E
Br J Pharmacol; 1985 Jun; 85(2):323-5. PubMed ID: 2992657
[TBL] [Abstract][Full Text] [Related]
4. The pharmacology of nedocromil sodium.
Eady RP
Eur J Respir Dis Suppl; 1986; 147():112-9. PubMed ID: 2429854
[TBL] [Abstract][Full Text] [Related]
5. Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells.
Wells E; Jackson CG; Harper ST; Mann J; Eady RP
J Immunol; 1986 Dec; 137(12):3941-5. PubMed ID: 2431049
[TBL] [Abstract][Full Text] [Related]
6. Monkeys infected with Ascaris suum (a new in vivo model of airway disease): protective effect of nedocromil sodium and sodium cromoglycate against bronchial antigen challenge.
Jackson DM; Eady RP
Eur J Respir Dis Suppl; 1986; 147():202-5. PubMed ID: 3021491
[TBL] [Abstract][Full Text] [Related]
7. A comparison of nedocromil sodium and sodium cromoglycate on human lung mast cells obtained by bronchoalveolar lavage and by dispersion of lung fragments.
Leung KB; Flint KC; Brostoff J; Hudspith BN; Johnson NM; Pearce FL
Eur J Respir Dis Suppl; 1986; 147():223-6. PubMed ID: 2429855
[TBL] [Abstract][Full Text] [Related]
8. Activity of nedocromil sodium in mast-cell-dependent reactions in the rat.
Riley PA; Mather ME; Keogh RW; Eady RP
Int Arch Allergy Appl Immunol; 1987; 82(1):108-10. PubMed ID: 3026967
[TBL] [Abstract][Full Text] [Related]
9. Nedocromil sodium. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease.
Gonzalez JP; Brogden RN
Drugs; 1987 Nov; 34(5):560-77. PubMed ID: 2826101
[TBL] [Abstract][Full Text] [Related]
10. Nedocromil, a mucosal and connective tissue mast cell stabilizer, inhibits exercise-induced asthma.
Shaw RJ; Kay AB
Br J Dis Chest; 1985 Oct; 79(4):385-9. PubMed ID: 2996580
[TBL] [Abstract][Full Text] [Related]
11. Nedocromil sodium is more effective than cromolyn sodium for the treatment of chronic reversible obstructive airway disease.
Lal S; Dorow PD; Venho KK; Chatterjee SS
Chest; 1993 Aug; 104(2):438-47. PubMed ID: 8393398
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the clinical efficacy of nedocromil sodium and placebo. How does cromolyn sodium compare as an active control treatment?
Schwartz HJ; Blumenthal M; Brady R; Braun S; Lockey R; Myers D; Mansfield L; Mullarkey M; Owens G; Ratner P; Repsher L; van As A
Chest; 1996 Apr; 109(4):945-52. PubMed ID: 8635375
[TBL] [Abstract][Full Text] [Related]
13. The effect of nedocromil sodium and cromolyn sodium on antigen-induced responses in allergic sheep in vivo and in vitro.
Abraham WM; Stevenson JS; Chapman GA; Tallent MW; Jackowski J
Chest; 1987 Nov; 92(5):913-7. PubMed ID: 2822361
[TBL] [Abstract][Full Text] [Related]
14. Nebulised sodium cromoglycate in the preschool wheezy child.
Lenney W; Milner AD
Arch Dis Child; 1978 Jun; 53(6):474-6. PubMed ID: 99089
[TBL] [Abstract][Full Text] [Related]
15. Adenosine-induced bronchoconstriction: comparison between nedocromil sodium and sodium cromoglycate.
Crimi N; Palermo F; Oliveri R; Cacopardo B; Vancheri C; Mistretta A
Eur J Respir Dis Suppl; 1986; 147():258-62. PubMed ID: 3021497
[TBL] [Abstract][Full Text] [Related]
16. Postgraduate course presentation. Cromolyn sodium in the treatment of asthma: changing concepts.
Bernstein IL
J Allergy Clin Immunol; 1981 Oct; 68(4):247-53. PubMed ID: 6169751
[No Abstract] [Full Text] [Related]
17. The clinical development of a new agent for the treatment of airway inflammation, nedocromil sodium (Tilade).
Auty RM
Eur J Respir Dis Suppl; 1986; 147():120-31. PubMed ID: 3021486
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of nedocromil sodium in asthma.
Holgate ST
Eur J Respir Dis Suppl; 1986; 147():149-59. PubMed ID: 3021489
[TBL] [Abstract][Full Text] [Related]
19. [Obstructive airway diseases and their management using dinatrium cromoglicicum].
Anolick GP; Schmidt OP; Primer G
Med Klin; 1975 Aug; 70(32-33):1290-5. PubMed ID: 818491
[No Abstract] [Full Text] [Related]
20. The preventive effect and duration of action of nedocromil sodium and cromolyn sodium on exercise-induced asthma (EIA) in adults.
König P; Hordvik NL; Kreutz C
J Allergy Clin Immunol; 1987 Jan; 79(1):64-8. PubMed ID: 3027153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
